Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pereyre, S.
Right arrow Articles by Bébéar, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pereyre, S.
Right arrow Articles by Bébéar, C. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 47, 240-241
© 2001 The British Society for Antimicrobial Chemotherapy

Correspondence

In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae

S. Pereyre, B. de Barbeyrac, H. Renaudin, F. Poutiers, C. Bébéar and C. M. Bébéar,*

Laboratoire de Bactériologie, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France

Sir,

Macrolides are a class of antibiotics commonly used for the treatment of mycoplasmal1 and chlamydial infections. They have been regarded as the drug of choice for the treatment of respiratory tract infections caused by the atypical microorganisms Mycoplasma pneumoniae and Chlamydia pneumoniae. Among this class, different molecules show various activities. Midecamycin diacetate is . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?